An MD and MSc-trained neurologist specializing in neuromuscular and electrodiagnostic medicine, she serves as director of the ALS Center and medical director of clinical trials in the Department of Neurology at NYU Langone Health, and is professor of neurology at NYU Grossman School of Medicine. Her clinical focus includes neuromuscular care, multidisciplinary neurologic management, and respiratory assessment and supportive intervention, with a strong commitment to improving access to clinical trials and emerging therapies. Her research interests center on clinical trial design, biomarker development, and precision therapeutics in neurodegenerative disease. She is an elected co-chair and scientific advisory board member of the Northeast ALS Consortium, co-principal investigator of the NIH-funded ALL ALS Consortium, and a steering committee member of Cures Collective. Her prior leadership roles include positions at Columbia University Irving Medical Center, Cytokinetics, Project ALS Therapeutics Core, Hospital for Special Care, and The ALS Association. Recognized for innovation and leadership, she has received the Healey International Prize for Innovation in ALS and the Diamond Award for ALS Clinical Research, and was nominated for the Sheila Essey Award from the American Academy of Neurology. She earned her MD from Albany Medical College, completed her neurology residency at the University of Connecticut School of Medicine, where she served as chief resident, and completed fellowships in neuromuscular disease and ALS and in clinical neurophysiology at Columbia University Irving Medical Center. She also holds an MSc in biostatistics from Columbia University Mailman School of Public Health.
Program Director
Medical School
1997 – 2001
Residency
2001 – 2002
Fellowship
2005 – 2006